002007 华兰生物
已收盘 05-22 15:00:00
资讯
新帖
简况
华兰生物：现金分红是公司回馈股东的重要方式
证券之星 · 05-20
华兰生物：现金分红是公司回馈股东的重要方式
华兰生物：华兰疫苗为公司自主设立，并非并购所得
证券之星 · 05-20
华兰生物：华兰疫苗为公司自主设立，并非并购所得
股市必读：华兰生物（002007）5月19日董秘有最新回复
证券之星 · 05-20
股市必读：华兰生物（002007）5月19日董秘有最新回复
华兰生物：公司将依规按时披露季报半年报年报
证券之星 · 05-18
华兰生物：公司将依规按时披露季报半年报年报
华兰生物：公司流感mRNA疫苗正按照研发计划稳步推进
证券之星 · 05-13
华兰生物：公司流感mRNA疫苗正按照研发计划稳步推进
股市必读：华兰生物（002007）5月11日董秘有最新回复
证券之星 · 05-12
股市必读：华兰生物（002007）5月11日董秘有最新回复
华兰生物：公司暂无剥离疫苗产业的计划
证券之星 · 05-11
华兰生物：公司暂无剥离疫苗产业的计划
华兰生物：截至2026年4月30日，公司共有14.6万多名投资者
证券之星 · 05-06
华兰生物：截至2026年4月30日，公司共有14.6万多名投资者
股市必读：华兰生物（002007）4月30日董秘有最新回复
证券之星 · 05-06
股市必读：华兰生物（002007）4月30日董秘有最新回复
华兰生物：公司持续关注AI技术在药物研发领域的发展动态
证券之星 · 04-27
华兰生物：公司持续关注AI技术在药物研发领域的发展动态
华兰生物：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响
证券之星 · 04-27
华兰生物：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响
华兰生物(002007.SZ)发布一季度业绩，归母净利润2.3亿元，同比下降26.44%
智通财经 · 04-26
华兰生物(002007.SZ)发布一季度业绩，归母净利润2.3亿元，同比下降26.44%
华兰生物（002007）披露获得《药品补充申请批准通知书》，4月20日股价下跌0.66%
证券之星 · 04-20
华兰生物（002007）披露获得《药品补充申请批准通知书》，4月20日股价下跌0.66%
华兰生物：2025年重庆华兰采浆量有所下降
证券之星 · 04-16
华兰生物：2025年重庆华兰采浆量有所下降
股市必读：华兰生物（002007）4月15日披露最新机构调研信息
证券之星 · 04-16
股市必读：华兰生物（002007）4月15日披露最新机构调研信息
华兰生物：截至2026年4月10日，公司共有14.7万多名投资者
证券之星 · 04-13
华兰生物：截至2026年4月10日，公司共有14.7万多名投资者
华兰生物（002007）披露2025年度业绩说明会安排，4月7日股价上涨1.03%
证券之星 · 04-07
华兰生物（002007）披露2025年度业绩说明会安排，4月7日股价上涨1.03%
华兰生物：截至2026年3月31日，公司共有14.8万多名投资者
证券之星 · 04-01
华兰生物：截至2026年3月31日，公司共有14.8万多名投资者
华兰生物（002007）披露2025年年度报告，3月30日股价上涨0.96%
证券之星 · 03-30
华兰生物（002007）披露2025年年度报告，3月30日股价上涨0.96%
华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.47%
证券之星 · 03-28
华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.47%
加载更多
公司概况
公司名称：
华兰生物工程股份有限公司
所属行业：
医药制造业
上市日期：
2004-06-25
主营业务：
华兰生物工程股份有限公司的主营业务是血液制品、疫苗、基因工程产品的研发、生产和销售。公司的主要产品是人血白蛋白、静注丙球、其他血液制品、流感疫苗。
发行价格：
15.74
{"stockData":{"symbol":"002007","market":"SZ","secType":"STK","nameCN":"华兰生物","latestPrice":13.86,"timestamp":1779433416000,"preClose":13.93,"halted":0,"volume":7704457,"delay":0,"changeRate":-0.005,"floatShares":1573000000,"shares":1827000000,"eps":0.4693,"marketStatus":"已收盘","change":-0.07,"latestTime":"05-22 15:00:00","open":13.92,"high":13.93,"low":13.77,"amount":107000000,"amplitude":0.0115,"askPrice":13.87,"askSize":155,"bidPrice":13.86,"bidSize":23,"shortable":0,"etf":0,"ttmEps":0.4693,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779672600000},"marketStatusCode":5,"adr":0,"adjPreClose":13.93,"symbolType":"stock","openAndCloseTimeList":[[1779413400000,1779420600000],[1779426000000,1779433200000]],"highLimit":15.32,"lowLimit":12.54,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1827456666,"isCdr":false,"pbRate":2.17,"roa":"--","peRate":29.533348,"roe":"1.98%","epsLYR":0.5151,"committee":0.526513,"marketValue":25329000000,"turnoverRate":0.0049,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-05-26。","floatMarketCap":21805000000},"requestUrl":"/m/hq/s/002007","defaultTab":"news","newsList":[{"id":"2636847998","title":"华兰生物：现金分红是公司回馈股东的重要方式","url":"https://stock-news.laohu8.com/highlight/detail?id=2636847998","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636847998?lang=zh_cn&edition=full","pubTime":"2026-05-20 20:52","pubTimestamp":1779281536,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物05月19日在投资者关系平台上答复投资者关心的问题。股民购买公司的股票是冲着这点分红来的吗？股价受市场环境、经营业绩及行业发展前景等多重因素综合影响。现金分红是公司回馈股东的重要方式，亦是落实监管导向、保障股东合理回报的重要举措。关于回购股份，需对公司经营情况、资金安排等综合考量，如有相关计划将及时履行信息披露义务，感谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000041266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0188","BK0239","BK0077","002007","BK0197","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636847689","title":"华兰生物：华兰疫苗为公司自主设立，并非并购所得","url":"https://stock-news.laohu8.com/highlight/detail?id=2636847689","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636847689?lang=zh_cn&edition=full","pubTime":"2026-05-20 20:52","pubTimestamp":1779281536,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月19日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在疫苗这块儿实在不怎么样，唯一的一次并购就是疫苗，还没成功，说好的新冠疫苗直到疫情结束都没能做出来，现在还拖累公司业绩，不如卖了专注血液制品创新华兰生物回复：您好，华兰疫苗为公司自主设立，并非并购所得。从合并报表口径而言，疫苗业务常年稳定贡献利润，并未长期拖累公司整体业绩。公司将同步做强血液制品主业并优化疫苗业务和重组蛋白药物业务。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000041262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002007","301207","BK0197","BK0046","BK0188","BK0028","BK0239","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636861966","title":"股市必读：华兰生物（002007）5月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2636861966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636861966?lang=zh_cn&edition=full","pubTime":"2026-05-20 03:49","pubTimestamp":1779220149,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，华兰生物报收于14.07元，上涨0.43%，换手率0.41%，成交量6.49万手，成交额9104.84万元。董秘最新回复投资者： 华兰生物股票二级市场持续低迷，公司董事长二年前增持华兰生物价格15元左右，今天盘中跌破14元了，公司是否有增持计划提振信心？股价受宏观环境、政策及行业发展前景等多重因素综合影响。当日关注点来自交易信息汇总：5月19日主力资金净流出143.22万元，占总成交额1.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000004912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0185","BK0046","BK0197","BK0077","002007","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636231710","title":"华兰生物：公司将依规按时披露季报半年报年报","url":"https://stock-news.laohu8.com/highlight/detail?id=2636231710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636231710?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:15","pubTimestamp":1779092117,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：以后能不能主动的预先披露下季报年报半年报？华兰生物回复：您好。根据监管规定，季报、半年报、年报均有法定披露时限，公司将依规按时披露，并在达到业绩预告标准时及时发布公告。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800022050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002007","BK0185","BK0028","BK0197","BK0188","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635202518","title":"华兰生物：公司流感mRNA疫苗正按照研发计划稳步推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2635202518","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635202518?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:00","pubTimestamp":1778662833,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司mRNA疫苗产品有哪些已在临床应用，流感mRNA疫苗研发进展如何？华兰生物回复：您好，公司流感mRNA疫苗正按照研发计划稳步推进，目前处于临床前研究阶段，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300030366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK0028","BK0077","BK0197","BK0188","002007","BK0046","BK0239","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634236219","title":"股市必读：华兰生物（002007）5月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2634236219","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634236219?lang=zh_cn&edition=full","pubTime":"2026-05-12 01:04","pubTimestamp":1778519056,"startTime":"0","endTime":"0","summary":"截至2026年5月11日收盘，华兰生物报收于14.95元，上涨2.82%，换手率1.97%，成交量31.01万手，成交额4.59亿元。董秘最新回复投资者： 有没有考虑过剥离疫苗产业，专注血液制品创新？交易信息汇总资金流向5月11日主力资金净流入583.86万元；游资资金净流入930.37万元；散户资金净流出1514.22万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200001196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0046","BK0028","BK0239","BK0077","BK0188","BK0185","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634332403","title":"华兰生物：公司暂无剥离疫苗产业的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2634332403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634332403?lang=zh_cn&edition=full","pubTime":"2026-05-11 15:12","pubTimestamp":1778483537,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月11日在投资者关系平台上答复投资者关心的问题。投资者提问：有没有考虑过剥离疫苗产业，专注血液制品创新？华兰生物回复：公司暂无剥离疫苗产业的计划，公司是一家从事血液制品、疫苗、基因工程产品研发、生产和销售的国家高新技术企业，公司业务包括血液制品、疫苗制品、创新药和生物类似药的研发、生产。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100014598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","159646","BK0197","BK0028","BK0185","002007","BK0188","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633902529","title":"华兰生物：截至2026年4月30日，公司共有14.6万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2633902529","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633902529?lang=zh_cn&edition=full","pubTime":"2026-05-06 15:48","pubTimestamp":1778053692,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年4月 30日公司的股东总数是多少？谢谢华兰生物回复：截至2026年4月30日，公司共有14.6万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600019870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","002007","BK0046","BK0077","BK0197","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633920960","title":"股市必读：华兰生物（002007）4月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2633920960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633920960?lang=zh_cn&edition=full","pubTime":"2026-05-06 05:40","pubTimestamp":1778017224,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，华兰生物报收于14.42元，下跌0.83%，换手率0.46%，成交量7.3万手，成交额1.06亿元。董秘最新回复投资者： 利妥昔单抗和曲妥珠单抗这两种药预计多久可以上市呢？公司参股公司华兰安康研发的利妥昔单抗注射液已完成Ⅲ期临床研究，并于2024年11月提交上市申请，目前正在接受CDE的技术审评，预计2026年获批上市；曲妥珠单抗已完成Ⅲ期临床研究，拟提交上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0046","BK0028","BK0239","BK0077","BK0188","BK0185","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630439111","title":"华兰生物：公司持续关注AI技术在药物研发领域的发展动态","url":"https://stock-news.laohu8.com/highlight/detail?id=2630439111","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630439111?lang=zh_cn&edition=full","pubTime":"2026-04-27 20:48","pubTimestamp":1777294087,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司管理层是否可以利用AI开发新型血制品的研发？华兰生物回复：您好！公司持续关注AI技术在药物研发领域的发展动态，并结合自身业务需求进行相关技术的探索与评估。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700042776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0077","BK0046","BK0028","BK0188","002007","BK0239","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630935075","title":"华兰生物：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2630935075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630935075?lang=zh_cn&edition=full","pubTime":"2026-04-27 15:18","pubTimestamp":1777274303,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：见信好，华兰生物一路破位下跌，3月份跌破15.3元关口之后一直修复无力。公司始终坚持稳健经营，持续提升核心竞争力，以扎实的业绩支撑公司长期价值。未来，公司将进一步提高信息披露质量，保持稳定分红，积极传递公司内在价值，切实维护投资者利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700021742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002007","BK0028","BK0197","BK0077","BK0239","BK0046","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630844493","title":"华兰生物(002007.SZ)发布一季度业绩，归母净利润2.3亿元，同比下降26.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630844493","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630844493?lang=zh_cn&edition=full","pubTime":"2026-04-26 17:48","pubTimestamp":1777196896,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华兰生物(002007.SZ)发布2026年第一季度报告，第一季度，公司实现营业收入7.62亿元，同比下降12.16%。归属于上市公司股东的净利润2.3亿元，同比下降26.44%。归属于上市公司股东的扣除非经常性损益的净利润2.27亿元，同比下降24.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"华兰生物(002007.SZ)发布一季度业绩，归母净利润2.3亿元，同比下降26.44%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628274622","title":"华兰生物（002007）披露获得《药品补充申请批准通知书》，4月20日股价下跌0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628274622","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628274622?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:35","pubTimestamp":1776677722,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘，华兰生物报收于14.94元，较前一交易日下跌0.66%，最新总市值为273.02亿元。该股当日开盘14.97元，最高15.04元，最低14.93元，成交额达9233.39万元，换手率为0.39%。华兰生物工程股份有限公司近日收到国家药品监督管理局核发的《药品补充申请批准通知书》，获准增加静注人免疫球蛋白2.5g/瓶和5g/瓶两种规格。本次获批将丰富公司血液制品规格矩阵，优化产品结构，提升市场竞争力。后续投产及销售受政策、市场等因素影响，存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000024588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0197","BK0046","002007","BK0239","BK0028","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627958752","title":"华兰生物：2025年重庆华兰采浆量有所下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2627958752","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627958752?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:12","pubTimestamp":1776330736,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问重庆华兰2025年采浆量为何减少？未来趋势如何？华兰生物回复：2025年重庆华兰采浆量有所下降，主要受区域存量浆站增长趋缓、新浆站尚未放量等因素影响；未来，随着巫山、丰都浆站逐步达产、存量浆站精细化运营推进，采浆量有望企稳修复，预计未来将保持稳定增长。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600030665.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0197","BK0028","BK0185","002007","BK0188","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627314772","title":"股市必读：华兰生物（002007）4月15日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2627314772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627314772?lang=zh_cn&edition=full","pubTime":"2026-04-16 01:38","pubTimestamp":1776274689,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，华兰生物报收于15.02元，上涨0.54%，换手率0.61%，成交量9.61万手，成交额1.44亿元。来自机构调研要点：利妥昔单抗预计2026年上市，公司持续推进多款创新药及疫苗研发。利妥昔单抗预计2026年上市；贝伐单抗为2025年首个上市产品，正推进挂网销售，后续产品将逐步放量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600002220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0188","BK0239","BK0077","002007","BK0197","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627310262","title":"华兰生物：截至2026年4月10日，公司共有14.7万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2627310262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627310262?lang=zh_cn&edition=full","pubTime":"2026-04-13 08:24","pubTimestamp":1776039849,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)04月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年4月10日，公司股东人数多少？华兰生物回复：截至2026年4月10日，公司共有14.7万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300001101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0197","002007","BK0046","BK0239","BK0188","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625594099","title":"华兰生物（002007）披露2025年度业绩说明会安排，4月7日股价上涨1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625594099","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625594099?lang=zh_cn&edition=full","pubTime":"2026-04-07 22:27","pubTimestamp":1775572034,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，华兰生物报收于14.76元，较前一交易日上涨1.03%，最新总市值为269.73亿元。近日，华兰生物工程股份有限公司发布公告，宣布将于2026年4月15日15:30-17:00通过深圳证券交易所“互动易”平台举行2025年度业绩说明会。公司已披露《2025年年度报告》及其摘要，并面向投资者提前征集问题，投资者可通过“互动易”平台进入指定界面提交提问，公司将在信息披露允许范围内就普遍关注的问题进行回应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700033585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0239","BK0077","BK0028","BK0197","002007","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624971560","title":"华兰生物：截至2026年3月31日，公司共有14.8万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2624971560","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624971560?lang=zh_cn&edition=full","pubTime":"2026-04-01 15:15","pubTimestamp":1775027720,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年3月31日，公司股东人数多少？华兰生物回复：截至2026年3月31日，公司共有14.8万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100022175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0077","BK0046","BK0028","BK0188","BK0239","BK0197","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623131393","title":"华兰生物（002007）披露2025年年度报告，3月30日股价上涨0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623131393","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623131393?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:29","pubTimestamp":1774862979,"startTime":"0","endTime":"0","summary":"截至2026年3月30日收盘，华兰生物报收于14.68元，较前一交易日上涨0.96%，最新总市值为268.27亿元。近日，华兰生物工程股份有限公司披露《2025年年度报告》。公告显示，截至2025年末，公司总资产为15,262,266,713.76元，归属于上市公司股东的净资产为11,500,605,548.73元。2025年营业收入为4,595,017,702.01元，同比增长4.93%；归属于上市公司股东的净利润为940,400,665.87元，同比下降13.55%；扣除非经常性损益后的净利润为936,794,228.45元，同比下降4.51%。经营活动产生的现金流量净额为877,956,500.25元，同比下降17.12%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000024030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0197","BK0188","002007","BK0046","BK0239","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622857133","title":"华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622857133","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622857133?lang=zh_cn&edition=full","pubTime":"2026-03-28 17:05","pubTimestamp":1774688738,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华兰生物披露，截至2026年3月10日公司股东户数为14.9万户，较2月28日减少2217.0户，减幅为1.47%。在生物制品行业个股中，华兰生物股东户数高于行业平均水平，截至3月10日，生物制品行业平均股东户数为3.48万户。从股价来看，2026年2月28日至2026年3月10日，华兰生物区间跌幅为0.71%，在此期间股东户数减少2217.0户，减幅为1.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800021720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","BK0185","BK0188","BK0197","002007","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779582573958,"stockEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0692},{"period":"3month","weight":-0.0947},{"period":"6month","weight":-0.1052},{"period":"1year","weight":-0.1008},{"period":"ytd","weight":-0.0839}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0076},{"period":"6month","weight":0.0725},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华兰生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"146000人(较上一季度减少0.68%)","perCapita":"10775股","listingDate":"2004-06-25","address":"河南省新乡市红旗区华兰大道甲1号","registeredCapital":"182745万元","survey":" 华兰生物工程股份有限公司的主营业务是血液制品、疫苗、基因工程产品的研发、生产和销售。公司的主要产品是人血白蛋白、静注丙球、其他血液制品、流感疫苗。","listedPrice":15.74},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰生物,002007,华兰生物股票,华兰生物股票老虎,华兰生物股票老虎国际,华兰生物行情,华兰生物股票行情,华兰生物股价,华兰生物股市,华兰生物股票价格,华兰生物股票交易,华兰生物股票购买,华兰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}